The ophthalmic guidewire is designed to navigate vessels to reach a lesion or vessel segment. Once the tip of the device arrives at its destination, it acts as a guide that larger catheters can rapidly follow for easier delivery to the treatment site. The ophthalmic guidewire is characterized by their usability, steerability, torque, and opacity. Pushability is the amount of force needed to advance the wire. Steerability is the ability and responsiveness of the wire tip to navigate vessels. Torque is the response of the cable to turning by the operator when navigating vessels. Its opacity is its level of visibility under fluoroscopic imaging. The primary functions of the Ophthalmic Guidewire are to access the lesion, to cross the lesion atraumatically, to provide support for interventional devices and the has ability to bend with direct pressure. Ophthalmic guidewire has an ability to follow the wire tip around curves and bends without bucking or kinking, to navigate anatomy of the vasculature.
Due to the COVID-19 pandemic, the global Ophthalmic Guidewire market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Ophthalmic Guidewire market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Ophthalmic Guidewire landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
Geographically, North America is anticipated to record a high market share of the market during the forecast period in the Ophthalmic Guidewire market owing to the well-developed healthcare infrastructure. Europe is anticipated to be the second leading region in the Ophthalmic Guidewire market attributing to the rising awareness of Ophthalmic Guidewire amongst the individuals, and healthcare professionals have fueled the Ophthalmic Guidewire market. The Asia-Pacific market is expected to record a robust CAGR during the forecast period. This growth can be attributed to the significant contribution from the emerging countries such as China and India. The growth in this region is attributed to the increase in funding for research and development and entry of established players in these regions.
This report focuses on Ophthalmic Guidewire volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Ophthalmic Guidewire market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.
Global Ophthalmic Guidewire Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Stainless Steel
Nitinol
Segment by Application
Hospitals
Clinics
Ophthalmic Centers
Ambulatory Surgical Centers
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Boston Scientific
Abbott Vascular
Terumo
Medtronic
BD
Cook Medical
Asahi Intecc
Abbott